These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 16698729)

  • 21. Behavioral test methods workshop.
    Slikker W; Acuff K; Boyes WK; Chelonis J; Crofton KM; Dearlove GE; Li A; Moser VC; Newland C; Rossi J; Schantz S; Sette W; Sheets L; Stanton M; Tyl S; Sobotka TJ
    Neurotoxicol Teratol; 2005; 27(3):417-27. PubMed ID: 15939202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Developmental neurotoxicity guideline study: issues with methodology, evaluation and regulation.
    Tsuji R; Crofton KM
    Congenit Anom (Kyoto); 2012 Sep; 52(3):122-8. PubMed ID: 22925212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Useful toxicologic neuropathology references for pathologists and toxicologists.
    Bolon B; Bradley A; Garman RH; Krinke GJ
    Toxicol Pathol; 2011 Jan; 39(1):234-9. PubMed ID: 21078920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and analysis of the central nervous system.
    Jordan WH; Young JK; Hyten MJ; Hall DG
    Toxicol Pathol; 2011 Jan; 39(1):58-65. PubMed ID: 21139057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perspectives on past practices and future trends in toxicologic neuropathology: notes from a keynote address by Dr. Peter S. Spencer.
    Bolon B
    Toxicol Pathol; 2011 Jan; 39(1):15-8. PubMed ID: 21075919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurooncology.
    Bradley AE; Keane K
    Toxicol Pathol; 2011 Jan; 39(1):124-8. PubMed ID: 21378208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene expression, biomarkers, and glial cells in nervous system diseases.
    Sills RC; Garman RH
    Toxicol Pathol; 2011 Jan; 39(1):97-8. PubMed ID: 21147932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recommended neuroanatomical sampling practices for comprehensive brain evaluation in nonclinical safety studies.
    Switzer RC; Lowry-Franssen C; Benkovic SA
    Toxicol Pathol; 2011 Jan; 39(1):73-84. PubMed ID: 21378207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The potential of mechanistic information organised within the AOP framework to increase regulatory uptake of the developmental neurotoxicity (DNT) in vitro battery of assays.
    Sachana M; Willett C; Pistollato F; Bal-Price A
    Reprod Toxicol; 2021 Aug; 103():159-170. PubMed ID: 34147625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Developmental neurotoxicity testing: a path forward.
    Crofton KM; Mundy WR; Shafer TJ
    Congenit Anom (Kyoto); 2012 Sep; 52(3):140-6. PubMed ID: 22925214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulatory Forum Opinion Piece*: Effective Brain Trimming for Regulatory-type Nonclinical Toxicity Studies.
    Bolon B
    Toxicol Pathol; 2018 Feb; 46(2):115-120. PubMed ID: 29278994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and analysis of the peripheral nervous system.
    Jortner BS
    Toxicol Pathol; 2011 Jan; 39(1):66-72. PubMed ID: 21078921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EEG as a cross species indicator of neurotoxicity.
    Benignus VA
    Neurobehav Toxicol Teratol; 1984; 6(6):473-83. PubMed ID: 6531053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biomarkers of adult and developmental neurotoxicity.
    Slikker W; Bowyer JF
    Toxicol Appl Pharmacol; 2005 Aug; 206(2):255-60. PubMed ID: 15967216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determining normal variability in a developmental neurotoxicity test: a report from the ILSI Research Foundation/Risk Science Institute expert working group on neurodevelopmental endpoints.
    Raffaele KC; Fisher JE; Hancock S; Hazelden K; Sobrian SK
    Neurotoxicol Teratol; 2008; 30(4):288-325. PubMed ID: 18280700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Scientific and regulatory issues relevant to assessing risk for developmental neurotoxicity: an overview.
    Rees DC; Francis EZ; Kimmel CA
    Neurotoxicol Teratol; 1990; 12(3):175-81. PubMed ID: 2196418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of histopathology in the identification of immunotoxicity.
    Haley PJ
    J Immunotoxicol; 2005 Oct; 2(4):181-3. PubMed ID: 18958671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The World weighs in on optimal toxicologic pathology training practices: it's unanimous!
    Bolon B
    Toxicol Pathol; 2011 Jan; 39(1):294. PubMed ID: 21378210
    [No Abstract]   [Full Text] [Related]  

  • 40. A modern approach to toxicologic pathology of the nervous system. Eighth international symposium of the Society of Toxicologic Pathologists. Cincinnati, Ohio, May 21-25, 1989. Proceedings.
    Toxicol Pathol; 1990; 18(1 Pt 2):81-223. PubMed ID: 2367809
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.